Despite the increased spending on MSK therapies between 2010 and 2019, many MSK treatments simply aren't providing a long-term solution, instead relying on "quick fix" injections or costly surgeries. (Photo: Shutterstock)
A new report finds that treatment of musculoskeletal (MSK) issues has doubled in recent years—with no improvement in patient outcomes.
The "State of MSK Report, 2021" was released by Hinge Health, a digital health company that specializes in MSK treatment. The report noted that MSK issues are a top health care cost for many employers, and that the new trend toward remote work may result in an increase in claims in this area, since many home workspaces are not set up to be ergonomically sound.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
